Cite
HARVARD Citation
Suda, G. et al. (2017). Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus‐infected patients with renal impairment. Hepatology research. 47 (11), pp. 1127-1136. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Suda, G. et al. (2017). Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus‐infected patients with renal impairment. Hepatology research. 47 (11), pp. 1127-1136. [Online].